Kang Stem Biotech

Stem cell-based therapies primarily for inflammatory and autoimmune diseases

placeSeoul, Seoul, South Korea calendar_todayFounded 2010 groups113 employees language kangstem.com

Innovation

8 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 170 times.

YearFilings
20145
20151
20163
20174
20181
20191
20211
20241

Social engagement

Social engagement: 630 social following, 8 posts in the last 12 months — above the industry median.

Investor mix

8 investors on record.

Investor typeCountShare
Venture capital563%
Private equity338%

Recent activity

19 Feb 2026
Milestone
regulatory
7 Jan 2026
Event
J.P. Morgan Healthcare Conference 2026
24 Dec 2025
Partnership
Institut Pasteur Korea
Coming soon